Piramal Enterprises Limited 0.61 % Pharmaceuticals

Trend Analysis

Loading...

Support and Resistance Levels Analysis
The current close value 2246.0 is between the support and resistance channel of 2045 and 2343. The stock has a Sell Signal , 2045 becomes a critical support to stop the fall and 2343 is a immediate resistance on the upside.

Technical Indicators (3 Month duration)
Exponential Moving average 2256.1
MACD value -143.5
Price range 2108.50 to 3199.75
Volume range 190669 to 834529
Support & Resistance 2045, 2343
Stock Performance
Six Months -14.8%
Five Months-6.6%
Four Months-13.6%
Three Months-10.2%
Two Months-16.9%
One Month-26.3%
Last Six Months

-14.8%

Last Five Months

-6.6%

Last Four Months

-13.6%

Last Three Months

-10.2%

Last Two Months

-16.9%

Last One Month

-26.3%

Analysis
Volume
Today's Price Range
3 Month Price Range
About Piramal Enterprises Limited
Piramal Enterprises Limited, an Indian-based company is focused on pharmaceutical business, financial services and information management. The pharmaceutical segment includes Pharma Solutions, Critical Care, OTC and Ophthalmology, and Life Sciences. Pharma Solutions cover the entire drug-cycle, from development and manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. The Critical Care division offers inhalation anesthetics, such as Sevoflurane and Desflurane. OTC and Ophthalmology division includes products, such as Caladryl, Equal and Saridon. The Life Sciences division discovers and optimizes compounds in the areas, including Imaging, New Chemical Entity Research and Bio-orthopaedics. The financial services segment offers fund raising, deployment, monitoring and exit of real estate loans and investments services. The information management segment is a provider of syndicated research, information and analytics to the healthcare industry.
See stocks similar to Piramal Enterprises Limited in Pharmaceuticals

Piramal Enterprises Limited has Sell Signal. What is your opinion on it?

{ }